News & Media — Team


Upcoming visit to Australia
Elham Shirani, PhD
Biomedical Engineer

Excited to be heading back to Australia for a mix of productive meetings and some time-off in the warmth of Down Under! 🌅 It’ll be my first time since moving to London. I’ve arranged meetings at the Robinson Research Institute, University of Adelaide and my alma mater, Macquarie University, and I’m eager to connect with …

FemTech insights from a return to Stanford
Kaylie Mings, MSc
Product Development Engineer

🌞 If only all work trips could be in sunny California! Kicked things off with a meeting by the Marina, where I had the pleasure of chatting with Sara Naseri about Qvin and the immense untapped potential of menstrual effluent research. It’s inspiring to witness just how much has been accomplished in the past decade …

6 Lessons I Learned from Attending PODD and the MidAtlantic Capital Conference
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

As the co-founder of Calla Lily Clinical Care, I’m always on the lookout for the latest trends and insights shaping healthcare. And also opportunities to escape my children. Did I mention I have 3 pre-teen/teenagers? Recently, I had the opportunity to attend two distinctly different conferences: PODD (Partnership Opportunities in Drug Delivery) in Boston and …

Haley Clawsie Joins as Business Development & Research Intern

Excited to welcome Haley Clawsie to our team as our new Business Development & Research Intern. Currently pursuing her BBA in Finance and Business Law at Loyola Marymount University, Haley is temporarily swapping sunny Los Angeles ☀ for a new adventure (with slight change of scenery) in London. With a strong passion for purpose-driven innovation, …

Cell culture lab progress
Elham Shirani, PhD
Biomedical Engineer

I am proud that I have helped set up a fully operational cell culture lab dedicated to advancing research in the vaginal microbiome at Calla Lily Clinical Care! This accomplishment wouldn’t have been possible without the incredible support of my colleagues— Dr Serena de Gelidi, Stuart Prince, Ewa Radziwon, Dr Arturo Jose Mendoza Meinhardt, Kaylie …

Precious Kilimo joins as MBA Strategy Intern
Thang Vo-Ta
Co-Founder & CEO

A warm welcome from myself, Lara, and the entire Calla Lily Clinical Care Team to Precious Kilimo, who joins us as an MBA Intern from London Business School where she is a Mo Ibrahim Foundation Scholar. 🏛 Prior to business school, Precious was instrumental in scaling Maisha Meds, a Kenyan health tech non-profit from a $300k …

Returning to Stanford University / Stanford d.school
Kaylie Mings MSc
Product Development Engineer

I’m thrilled to be heading back to Stanford University and The Stanford d.school for the first time since graduating! I’ll be in the Bay Area next week from October 21st, representing Calla Lily Clinical Care 🌸. I’m excited to reconnect with professors, industry leaders, and former collegues on our exciting Callavid and Phlovid progress. I’d …

Dr. Emma Parry Joins as a Zinc NIHR Innovation Fellow

We’re delighted to welcome Dr. Emma Parry to our team as a Zinc NIHR Innovation Fellow! Emma brings invaluable expertise from her role as a clinical GP in Birmingham and as an academic GP at Royal Wolverhampton Hospitals NHS Trust. As we continue developing our patient-centric vaginal drug delivery system, Emma will play a key …

Reflections from a Summer with Calla Lily Clinical Care
Marielle Todd
Research & Marketing Intern

As I reflect on my summer internship with Calla Lily Clinical Care, I feel immense gratitude to the people who made my experience impactful. Navigating a new country and industry, I was a fish out of water, but everyone at CLCC welcomed me with open arms. I was encouraged to ask questions, explore new ideas, …

Reflecting on 18+ months at Calla Lily
Kaylie Mings MSc
Product Development Engineer

Long overdue, but I have been reflecting on my last 18+ months at Calla Lily Clinical Care. From starting my first day by jetting off to Paris to Pharmapack Europe to setting up our incredible new office and labs to acquiring funding for our first in-women clinical trials of our drug delivery technology next year: …

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.